MILD HYPERCORTISOLISM DUE TO ADRENAL ADENOMA: IS IT REALLY SUBCLINICAL?

Similar documents
Subclinical Cushing s Syndrome

Endocrine MR. Jan 30, 2015 Michael LaFata, MD

Dimitrios Linos, M.D., Ph.D. Professor of Surgery National & Kapodistrian University of Athens

Approach to Adrenal Incidentaloma. Alice Y.Y. Cheng, MD, FRCP

The Evaluation of the Incidental Adrenal Mass and Not-So-Incidental Adrenal Hormone Excess

Differential Diagnosis of Cushing s Syndrome

AVS and IPSS: The Basics and the Pearls William F. Young, Jr., MD, MSc Professor of Medicine Mayo Clinic College of Medicine Rochester, MN, USA

Adrenal incidentaloma guideline for Northern Endocrine Network

27 F with new onset hypertension and weight gain. Rajesh Jain Endorama 10/01/2015

Endocrine Topic Review. Sethanant Sethakarun, MD

William F. Young, Jr., MD, MSc Professor of Medicine, Mayo Clinic, Rochester, MN USA

Mineralocorticoids: aldosterone Angiotensin II/renin regulation by sympathetic tone; High potassium will stimulate and ACTH Increase in aldosterone

ADRENAL INCIDENTALOMA. Jamii St. Julien

AVS and IPSS: The Basics and the Pearls

C h a p t e r 3 8 Cushing s Syndrome : Current Concepts in Diagnosis and Management

TREATMENT OF CUSHING S DISEASE

Adrenal Incidentalomas. Dr A Tabarin University Hospital of Bordeaux (France)

The Management of adrenal incidentaloma

The Work-up and Treatment of Adrenal Nodules

CUSHING SYNDROME Dr. Muhammad Sarfraz

14 Girl with Cushing s Disease: An Update. Kristen Dillard, MD Endorama October 17, 2013

57-year-old man with anxiety, diaphoresis, fatigue and bilateral adrenal nodules. Celeste Thomas November 1, 2012

How to Recognize Adrenal Disease

October 13, Surgical Nuances to Managing Cushing s Disease. Cortisol Regulation. Cushing s Syndrome Excess Cortisol. Sandeep Kunwar, M.D.

Cushing s Syndrome. Diagnosis. GuidelineCentral.com. Key Points. Diagnosis

in Primary Care (Part 2) Jonathan R. Anolik, MD, FACP, FACE Lewis Katz School of Medicine at Temple University

Endocrine. Endocrine as it relates to the kidney. Sarah Elfering, MD University of Minnesota

Incidental Adrenal Nodules Differential Diagnosis

Il Carcinoma Surrenalico

Current Management of Adrenal Cortical Carcinoma

Physiology. The Hypothalamic Pituitary Adrenal Axis. Elena A Christofides, MD, FACE

Inquadramento Clinico dell IncIdentaloma SurrenalIco

Cortisol levels. Naturally produced by the adrenal Cortisol

Case Based Urology Learning Program

Pituitary Adenomas: Evaluation and Management. Fawn M. Wolf, MD 10/27/17

A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas: No Tumor Growth or Development of Hormonal Hypersecretion

ADRENAL DISORDERS Anand Vaidya, MD MMSc

CHOLESTEROL IS THE PRECURSOR OF STERIOD HORMONES

THE WORK-UP OF ADRENAL INCIDENTALOMA

Stelios Mantis, MD DuPage Medical Group Pediatric Endocrinology

Adrenal Mass. Cynthia Kwong SUNY Downstate Medical Center Grand Rounds October 13, 2016

Diseases of the Adrenal gland

Evaluation of Thyroid Nodules

RECURRENT ADRENAL DISEASE. Megan Applewhite Endorama 2/19/2015 SR , SC

Adrenal Incidentalomas. G Stephen DeCherney, MD, MPH Clinical Professor of Medicine Division of Endocrinology UNC School of Medicine

Primary Aldosteronism

ULTIMATE BEAUTY OF BIOCHEMISTRY. Dr. Veena Bhaskar S Gowda Dept of Biochemistry 30 th Nov 2017

Adrenal Disorders for the USMLE, Step One: Abnormalities of the Fasciculata: Hypercortisolism

Adrenal Incidentaloma Management

3- & 12-Year-Old Sisters with Li-Fraumeni Syndrome KRISTEN DILLARD, M.D. ENDORAMA FEBRUARY 28, 2013

The endocrine system is made up of a complex group of glands that secrete hormones.

Morbidity & Mortality. Mark H. Tseng MD SUNY Downstate Medical Center Lutheran Medical Center December 16, 2005

Therapeutic Objectives. Cushing s Disease Surgical Results. Cushing s Disease Surgical Results: Macroadenomas 10/24/2015

Functional Pituitary Adenomas. Fawn M. Wolf, MD 2/2/2018

SECONDARY HYPERTENSION

High and Low GH: an update of diagnosis and management of GH disorders

Sean Hamlett DO FACOI Endocrinology, Diabetes, and Metabolism Freeman Health System Joplin, MO

Radiology reporting of adrenal incidentalomas who requires further testing?

A short & obese - girl

Endocrine Hypertension

Indications for Surgical Removal of Adrenal Glands

Pituitary Gland Disorders

Adrenal Ganglioneuroma Presenting With Adrenal Insufficiency After Unilateral Adrenalectomy

PITUITARY: JUST THE BASICS PART 2 THE PATIENT

COPYRIGHTED MATERIAL. Adrenal Imaging. 1.1 Introduction. Khaled M. Elsayes 1, Isaac R. Francis 1, Melvyn Korobkin 1 and Gerard M.

Adrenal gland Incidentaloma

Cushing s syndrome and adrenal insufficiency

Endocrine Testing. Alice Y.Y. Cheng, MD, FRCP October 14, 2015

Pituitary Tumors and Incidentalomas. Bijan Ahrari, MD, FACE, ECNU Palm Medical Group

Year 2004 Paper two: Questions supplied by Megan 1

Approach to a patient with hypercalcemia

Cushing s syndrome with no clinical stigmata a variant of glucocorticoid. resistance syndrome.

Upon completion, participants should be able to:

John Sutton, DO, FACOI, FACE, CCD. Carson Tahoe Endocrinology Carson City, NV KCOM Class of 1989

Original Research Article

The Pathological l Basis of Disease

ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain

Trust Guideline for the Investigation of Incidental Adrenal Masses in Adults

How to approach resistant hypertension. Teh-Li Huo, M.D., Ph.D.

Evaluation of Endocrine Tests B: screening for hypercortisolism

2

Kristen Dillard, M.D. Endorama December 6, 2012

Practical Management of Steroids in Non-Endocrine Practice

A case of failed bariatric surgery

The Adrenal Glands. I. Normal adrenal gland A. Gross & microscopic B. Hormone synthesis, regulation & measurement. II.

ACTH-dependent Cushing s Syndrome Update AACE MI Chapter Annual Meeting September 22, Lynnette K. Nieman DEOB, NIDDK, NIH, DHHS

Audit of Adrenal Function Tests. Kate Davies Senior Lecturer in Children s Nursing London South Bank University London, UK

Pseudo-Endocrine Disorders Practical Management Strategies

Pseudo-Endocrine Disorders Practical Management Strategies

Adrenal Update. Mohamed Ahmed MRCP(UK),MRCP-Endo(London),Diabetes Dip. Consultant Physician HEFT

301 S. Westfield Rd., Suite 250 Madison, WI See inside for information about our Endocrine Surgery Referral Program

Adrenal Disorders for the USMLE, Step One: Abnormalities of the Fasciculata: Hypocortisolism

Adrenal disease Real and Unreal. Objectives. Real

Primary Aldosteronism: screening, diagnosis and therapy

ENDOCRINOLOGY 3. R. A. Benacka, MD, PhD, prof. Department of Pathophysiology Medical faculty, Safarik University, Košice

Endocrine Surgery When to Refer and What We Do

PROBLEMS WITH REGULATION AND METABOLISM. Objectives A & P 8/11/2011

Prevalence of adrenal incidentaloma a methodologic comparison of EMR query strategies

The analysis of Glucocorticoid Steroids in Plasma, Urine and Saliva by UPLC/MS/MS

The Investigation of suspected paediatric Cushing s Syndrome (hypercortisolaemia)

Transcription:

MILD HYPERCORTISOLISM DUE TO ADRENAL ADENOMA: IS IT REALLY SUBCLINICAL? Alice C. Levine, MD Professor of Medicine Division of Endocrinology, Diabetes and Bone Diseases Georgia-AACE 2017 Annual Meeting Atlanta, GA January 27-28, 2017

none Disclosures

Case 68 yo F with adrenal mass noted on CT-urogram Dedicated CT showed 3.0 cm left adrenal mass with HU of -3 c/w benign adrenal adenoma PMHx: HTN, hyperlipidemia, osteopenia with vertebral FX and impaired glucose tolerance ROS: weight gain of 25 lbs in 18 months

Insert pt s CT here Imaging

Case PE: BP 155/88, no scalp hair loss or hirsutism, slight increased dorsocervical fat pad, obese abdomen, no striaie, no LE edema, adenoma proximal muscle weakness or wasting Mild hypercortisolism due to adrenal? Further workup or treatment? Laboratory w/u: PM cortisol 6.5 mcg/dl, ACTH <10 DHEA-S = 31 mcg/dl (low) Midnight salivary cortisols:1.4 nmol/l and 1.6 nmol/dl (nl) 1 mg dex suppression - cortisol 6.1 mcg/dl 24-hr UFC 55mcg/24 hr and 49 mcg/24 hr (upper limit 45) Aldosterone 7.0 ng/dl, PRA 0.4 Serum catecholamine levels normal

Lindsay et al. Endocrine Reviews 2005;26:775-799 6

Cushing Syndrome Excess glucocorticoids cause Cushing Syndrome may be exogenous or endogenous Screening Tests 24 hour urine for urinary free cortisol Midnight salivary cortisols 1 mg overnight dexamethasone suppression test with measurement of AM serum cortisol, ACTH and dexamethasone levels **Not useful in women on OCPs

Adrenal Cushing Epidemiology Biochemical Diagnosis Sequelae Treatment Options

Adrenal Incidentaloma Any serendipitously identified mass of >1 cm in the adrenal glands Autopsy studies suggest the rate of clinical unapparent nodules identified at death to be 6% Incidence increases with age Most are non-secreting and benign adenomas

Incidentaloma and the Beatles EMI scanner (aka CT scan): 1972 Developed by Sir Godfrey Newbold Hounsfield in Britain at Electric and Musical Industries (EMI) Central Research Laboratories Brain scans only Required a water-filled, pre-shaped rubber "head-cap

Incidentaloma First appeared in the scientific literature in 1970 s First publication discussing adrenal incidentalomas 19% of patients had an incidentally found adrenal lesion Unsuspected primary and metastatic neoplasms of the adrenals were occasionally detected in patients scanned for other reasons. CT seems to be a simple and accurate method to assess the adrenal glands in patients suspected of adrenal disease.

Adrenal Incidentaloma Prevalence: 1% - 32 Age: <30 years of age: 0.2% >70 years of age: 6.9 % Overwhelming majority are benign (particularly if <3 cm)

Adrenal Incidentaloma Hormonal Activity 4-5% Cortisol Phoechromocytoma Aldosterone ACC Non-Secreting Young WF, NEJM, 2007

Adrenal Incidentaloma Hormonal Activity 30% Cortisol Pheo Aldosterone ACC Non-secreting Dalmazi GD et al, Lancet, 2014

Risk Factors for Adrenal Cushing Bilateral Tumors Tumors larger than 2.4 cm diameter Somatic mutations in the catalytic subunit of protein kinase A (PRKACA) present in 1/3 of adenomas associated with overt Cushing

Adrenal Cushing Subclinical Cushing?

Adrenal Cushing Epidemiology Biochemical Diagnosis Sequelae Treatment Options

Subclinical Cushing Laboratory Definitions Abnormal DST May or may not have altered circadian rhythms UFC is often normal or nearly normal ACTH may not be suppressed

Laboratory Definitions Chiodini I, J Clin Endocrinol Metab, 2011

1mg Overnight Dexamethasone Suppression Test AM Cortisol >1.8 ug/dl > 5 ug/dl Sensitivity* 75-100% 44-58% Specificity* 67-72% 83-100% \Diagnosis of Mild Hypercortisolism - AM Cortisol after 1mg Dexamethasone *Chiodini, I. Diagnosis and Treatment of Subclinical Hypercortisolism. JCEM, May 2011, 96(5): 1223-1236.

Adrenal Cushing Epidemiology Biochemical Diagnosis Sequelae Treatment Options

Subclinical Cushing Adverse effects on Bone Tachmanova et al. Eur J endo 2007, Morelli et al, J. Bone Mineral Res. 2011 (103 pts, 2 year followup) Chiodini et al., 2016, Eur. J Endo: BMD decrease spine, vertebral FX 46-82% Hypertension Insulin resistance/impaired glucose metabolism/body composition/nfld Ivovic et al. Metabolism 2013 Androulakis et al, JCEM 2014 DeBono M et al, JCEM 2013 (visceral fat accumulation) Papanastasiou L. et al, Eur J Clin. Inv. 2012 (NFLD) Duration of cortisol exposure is associated with increase risk for morbidity and mortality Lambert J et. al. (E. Geer) JCEM 2013 Increased cardiovascular risk

Hypercortisolism and CV Mortality Androulakis et al, JCEM 2014 Patients with apparently non-functioning AI at increased CV risk due to increased cortisol secretion. 60 pts with AI vs 32 Controls. Further stratified 60 AI into 26 CSAI (> 3mcg/dl post Dex), 34 NFAI. CSAI worse than NFAI worse than C.

% CV Disease 198 patients -114 stable nonsecretory, 61 stable with intermediate or SCC, 23 had worsening pattern. Average followup 7.5 years (range 26 mos. To 15 yrs) Dalmazi GD et al, Lancet, 2014

All Cause Mortality CV specific Mortality Dalmazi GD et al, Lancet, 2014

CVEs in AI: Morelli et al. JCEM 99:827-834, 2014 206 AI pts >5 yr followup SH = 1 mg dex with cortisol > 5mcg/dl or at least 2: low ACTH, high UFC, 1mg dex cortisol > 3 mcg/dl 24 pts with SH initially, 15 more developed over time (8.2%) (some with dex suppression > 1.8 mcg/dl initially). SH+ and SH- many grew and noted bilateral adenomas. SH patients more diabetes and CVEs and larger adenomas. Cutoff size >2.4 cm CVEs correlate with dex suppressed cortisol between 1.5 and 2.0 mcg/dl (best SN and SP)

What s in a Name? Any disease that has these sequelae is not subclinical Subclinical suggests that treatment is not necessary Mild Hypercortisolism

Back to our case 3cm adrenal incidentaloma in patient with metabolic syndrome and vertebral fracture NOT PRIMARY ALDOSTERONISM NOT PHEOCHROMOCYTOMA 24 hour urinary free cortisol mildly elevated, overnight dex suppression cortisol only suppressed to 6.1, low DHEAS and low ACTH Mild Hypercortisolism

Adrenal Cushing Epidemiology Biochemical Diagnosis Sequelae Treatment Options

Systematic review of surgical treatment of subclinical Cushing syndrome. Iacobone M et al. Brit J Surgery March 2015 J Surgery March 2015 105 papers screened;7 selected Laparascopic surgery preferred Improvement in HTN, metabolic parameters However, heterogeneity (particular in definition of SCC) and low quality of data preclude definitive recommendations.

Adrenalectomy reduces the risk of vertebral FX in patients with AI and mild hypercortisolism Salcuni AS et al, Eur. J. Endocrinology 2016 605 patients with unilateral adrenal incidentalomas 55/605 with mild hypercortisolism 32/55 had adrenalectomy, followup 2-3 years BMD increased in surgery group, less vertebral FX (30% risk reduction) than in the observation group 33

Innovations in the medical management of Cushing s syndrome seem akin to London s red buses- none come along for ages and then three arrive together, namely, mifepristone, pasireotide and LCI699 Peter Trainer (Manchester, UK, editorial JCEM April 2014, 99:1157-1160)

Adrenal Cushing Adrenal incidentalomas are increasingly common. As many as 30% may be producing small amounts of excess cortisol. Subclinical Cushing is not-so-subclinical. Even low levels of excess cortisol can contribute to obesity, metabolic syndrome, osteoporosis, cardivascular morbidity and mortality. Treatment options include observation, surgery and new medical therapies.

Thank you Gillian Goddard Aarti Ravikumar Nandita Sinha Jose Sanchez Escobar Eliza Geer Alexander Kirschenbaum